Abstract
Background: Multi-drug resistance of Pseudomonas aeruginosa comprises the most vital obstacles in the antibacterial fight worldwide. The innovation of novel and effective antibacterial and/or resistance modulators is crucial to variance the extent of resistance or to reverse multidrug resistance.
Objective: This study aimed to determine the in vitro antibacterial activity of the F.carica against the Pseudomonas aeruginosa associated with nosocomial infection.
Methods: We studied different extracts of F.carica in methanol, benzene and water with antibiotics and their synergistic effect against P. aeruginosa using minimum inhibitory concentration and fraction inhibitory concentration index.
Results: Our results revealed that the methanol extract of leaves possessed maximum phyto constituents and were active against P. aeruginosa. Methanol extracts of leaves alone and in combination with antibiotics showed a higher zone of inhibition and were synergistic (<0.5) compared to other extracts. Moreover, the combination of ofloxacin with all solvent extracts enhanced the synergistic antibacterial activity with respect to other antibiotics used.
Conclusion: We explored the synergistic effects of F. carica methanol extracts alone and with antibiotics was the most potential against P. aeruginosa.
Graphical Abstract
[http://dx.doi.org/10.1586/erp.10.49] [PMID: 20715920]
[http://dx.doi.org/10.1186/s13756-018-0307-3] [PMID: 29410782]
[http://dx.doi.org/10.1099/jmm.0.000742] [PMID: 29693543]
[http://dx.doi.org/10.5897/AJB07.613]
[http://dx.doi.org/10.1186/s13002-017-0166-7] [PMID: 28679438]
[http://dx.doi.org/10.3109/13880209.2014.892515] [PMID: 25017517]
[http://dx.doi.org/10.1016/j.foodchem.2014.04.112] [PMID: 24996314]
[http://dx.doi.org/10.4167/jbv.2009.39.2.97]
[http://dx.doi.org/10.1016/j.mycmed.2018.04.004] [PMID: 29730129]
[http://dx.doi.org/10.21786/bbrc/9.4/41]
[http://dx.doi.org/10.3923/ajdd.2015.13.23]
[http://dx.doi.org/10.1186/s12866-016-0765-9] [PMID: 27400878]
[http://dx.doi.org/10.5455/jice.20170106073231] [PMID: 28512606]
[http://dx.doi.org/10.1128/CMR.14.4.836-871.2001] [PMID: 11585788]
[http://dx.doi.org/10.3390/ijms221910746] [PMID: 34639087]
[http://dx.doi.org/10.1016/j.chroma.2005.11.047] [PMID: 16343519]
[http://dx.doi.org/10.1021/jf060497h] [PMID: 17002444]
[http://dx.doi.org/10.3390/medicines5010002] [PMID: 29301368]
[http://dx.doi.org/10.1016/S1995-7645(10)60064-8]
[http://dx.doi.org/10.1128/CMR.12.4.564] [PMID: 10515903]
[http://dx.doi.org/10.1248/bpb.30.1147] [PMID: 17541170]
[http://dx.doi.org/10.3389/fmicb.2017.01580] [PMID: 28878746]
[http://dx.doi.org/10.1016/j.jtcme.2015.09.002] [PMID: 27774426]